Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin vs Pancreatic Stenting for Prevention of Post-ERCP Pancreatitis
NCT03713879Phase 3Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2019
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by The Chinese University of Hong Kong. Started Mar 2019; status: recruiting.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT03713879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03713879.